In a regulatory filing, the company stated: “As previously announced on March 30, 2026, Richard Gelfond, the Chief Executive Officer of IMAX (IMAX) Corporation, is on a temporary medical leave of absence. On April 16, 2026, the Company’s board of directors appointed Robert D. Lister, the Company’s Chief Legal Officer and Senior Executive Vice President, to serve as the Company’s interim principal executive officer – “PEO” – in addition to his current duties until May 1, 2026, following which Mr. Gelfond will resume the role of PEO. Mr. Lister will not receive any additional compensation in connection with his temporary interim appointment.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMAX:
- Amazon Extends Its Blockbuster Hit’s Theater Run after Earning over $500M
- Why is Angel Studios Stock (ANGX) Up 7% Today?
- Ellison commits to 45-day movie release window, Variety reports
- Imax price target raised to $45 from $43 at Seaport Research
- IMAX CEO Takes Medical Leave, Leadership Team Oversees Operations